CVEvulnerability

CVE-2026-21997

8.5 HIGH Published 2026-04-21 Modified 2026-10-26 Official page ↗
Status
Analyzed
Published
2026-04-21
Last modified
2026-10-26
Assigner
[email protected]
CVSS 3.1 ([email protected])
8.5 HIGH — CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
Weaknesses
CWE-284

Description

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Affected configurations

• oracle life sciences empirica signal (>= 9.2.1 <= 9.2.3)

Related

Weakness · CWE (1)

  • CWE-284 Improper Access Control weakness

References